Home/Filings/4/0001209191-24-004239
4//SEC Filing

Elliott Jeffrey Thomas 4

Accession 0001209191-24-004239

CIK 0001124140other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 8:40 PM ET

Size

10.3 KB

Accession

0001209191-24-004239

Insider Transaction Report

Form 4
Period: 2024-02-29
Elliott Jeffrey Thomas
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-03-01$59.32/sh2,412$143,08010,933 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-02-295,29115,876 total
    Common Stock (5,291 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-29+5,29113,345 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,585
Footnotes (5)
  • [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
  • [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
  • [F3]In addition to the shares of Common Stock reported on this Form 4, which total 12,518 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F5]Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date.

Issuer

EXACT SCIENCES CORP

CIK 0001124140

Entity typeother

Related Parties

1
  • filerCIK 0001689757

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:40 PM ET
Size
10.3 KB